Only 41% of people would sign up for COVID-19 trials says new report

 E-Mail
Research conducted by the University of Birmingham shows in order to have an effective Covid-19 vaccination rollout it has to be widely accepted by the entire population.
The study, conducted in collaboration with the NIHR Clinical Research Network West Midlands and The Royal Wolverhampton NHS Trust was published in the journal
Trials involved an anonymous cross-sectional online survey across the UK involving 4884 participants of which 9.44% were Black Asian Minority Ethnic (BAME). Overall, 2020 (41.4%) respondents were interested in participating in vaccine trials, while 27.6% of the respondents were not interested and 31.1% were unsure. The most interested groups were male, graduates the 40-49 and 50-59 age groups and those with no health issues. The least interested groups were BAME those from villages and small towns and those aged 70 and above.

Related Keywords

United Kingdom ,West Midlands ,United Kingdom General ,Anandadeep Mandal ,Birmingham Business School ,Clinical Research Network West Midlands ,National Institute For Health Research ,University Of Birmingham ,Research Network West Midlands ,Royal Wolverhampton ,Black Asian Minority Ethnic ,National Institute ,Health Research ,ஒன்றுபட்டது கிஂக்டம் ,மேற்கு மிட்லாண்ட்ஸ் ,ஒன்றுபட்டது கிஂக்டம் ஜநரல் ,ஆனந்ததீப் மண்டல் ,பர்மிங்காம் வணிக பள்ளி ,மருத்துவ ஆராய்ச்சி வலைப்பின்னல் மேற்கு மிட்லாண்ட்ஸ் ,தேசிய நிறுவனம் க்கு ஆரோக்கியம் ஆராய்ச்சி ,பல்கலைக்கழகம் ஆஃப் பர்மிங்காம் ,ஆராய்ச்சி வலைப்பின்னல் மேற்கு மிட்லாண்ட்ஸ் ,கருப்பு ஆசிய சிறுபான்மை இன ,தேசிய நிறுவனம் ,ஆரோக்கியம் ஆராய்ச்சி ,